Predictive factors of 18F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?

被引:0
|
作者
Alison C. Johnson
Audrey Emmanuelle Dugué
Marlon Silva
Laura Moise
Xavier Tillou
Florence Joly
Nicolas Aide
机构
[1] François Baclesse Cancer Center,Department of Oncology
[2] François Baclesse Cancer Center,Department of Radiation Therapy
[3] University Hospital of Caen,Department of Urology
[4] University Hospital of Caen,Department of Nuclear Medicine
[5] François Baclesse Cancer Center,Department of Nuclear Medicine
来源
关键词
Biochemical recurrence; Radiation therapy; F-choline PET; Prostate cancer; PSA nadir;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] 18F-Choline PET/CT vs MR in Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 17N - 18N
  • [32] Treatment Volumes Definition in Prostate Radiation Therapy: The Role of 18F-Choline PET/CT
    Alongi, F.
    Fersino, S.
    Fiorentino, A.
    Mazzola, R.
    Ricchetti, F.
    Levra, N. Giaj
    Ruggieri, R.
    Salgarello, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E226 - E227
  • [33] Outcome of PET/CT 18F-Choline in high risk prostate cancer patients
    Lavados, H.
    Pruzzo, R.
    Amaral, H.
    Hernandez, E.
    Morales, B.
    Haeger, A.
    Fernandez, R.
    Hurtado, A.
    Galaz, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S435 - S435
  • [34] 18F-Choline PET/CT in biochemically relapsed prostate cancer
    Marzola, Maria Cristina
    Chondrogiannis, Sotirios
    Grassetto, Gaia
    Rampin, Lucia
    Ferretti, Alice
    Massaro, Arianna
    Fornasiero, Adriano
    Rubello, Domenico
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [35] Role of PSA kinetics in the detection rate of 18F-Choline PET/CT in restaging prostate cancer patients.
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Tadayyon, S.
    Rampin, L.
    Tommasi, E.
    Massaro, A.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S460 - S461
  • [36] Appropriateness of prescription of 18F-Choline PET/CT in 218 patients with prostate cancer
    Chondrogiannis, S.
    Marzola, M. C.
    Grassetto, G.
    Borotto, G.
    Tommasi, E.
    Tamiso, L.
    Maffione, A. M.
    Pavan, L.
    Rampin, L.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S719 - S719
  • [37] Optimizing the acquisition protocol of 18F-Choline PET/CT in prostate cancer patients
    Massaro, Arianna
    Cittadin, Silvia
    Milan, Elisa
    Tamiso, Luca
    Lara, Pavan
    Enrico, Tommasi
    Marzola, Maria Cristina
    Grassetto, Gaia
    Rubello, Domenico
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [38] Impact of 18F-Choline PET-CT on the selection of patients with oligometastatic prostate cancer recurrence candidates for local salvage treatments
    Fernandez-Tercero, I. L.
    Gomez-Iturriaga, A.
    Sanchez-Salmon, A.
    Casquero, F.
    Urresola, A.
    Ezquerro, A. I.
    Llarena, R.
    Rodeno, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S339 - S339
  • [39] 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer
    Quero, Laurent
    Vercellino, Laetitia
    de Kerviler, Eric
    Mongiat-Artus, Pierre
    Culine, Stephane
    Merlet, Pascal
    Ravery, Vincent
    Meria, Paul
    Desgrandchamps, Francois
    Hennequin, Christophe
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) : e492 - e495
  • [40] Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
    Marco, Rensi
    Guido, Ferretti
    Fernando, Di Gregorio
    Laura, Evangelista
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : E116 - E117